The Omicron Wave in India, Mumbai, and Delhi: Prevalence and Pathogenicity



Abstract Views
828

Downloads
352

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted May 28, 2022
Published Jun 22, 2022
10.24018/ejmed.2022.4.3.1376

Abstract viewed = 828 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

The dynamics of the Omicron variant in India, Mumbai, and Delhi have been studied. The % share of the Omicron variant in overall India rose from 0.35% to 97.12% during the period November 29, 2021, to February 7, 2022. Due to the emergence of the Omicron variant, the daily new infections in India rose from a baseline tally of below 8,000 cases to the highest number of 347,063 cases recorded on January 20, 2022. In Mumbai, the Omicron variant completely replaced the Delta and other lineages as reported on March 3, 2022 genome sequencing report. In Mumbai because of the Omicron variant surge, the new infections rose to 20,971 on January 7, 2022, from a baseline tally of 191 daily cases recorded after receding the second Delta variant wave. In real-time, the vaccine effectiveness among the Indian population during the Omicron variant surge was studied and noticed that the two-dose regimen was 99.3% effective in preventing death. The death rate among the hospitalized patients was reduced by 12% among the vaccinated individuals compared to the unvaccinated ones. During the Omicron variant wave, the average age of the COVID-19 patients shifted by 11 years towards the younger age which was because the vaccination among the younger population was low compared to the elderly population.

Keywords: Mortalities prevention, Omicron pathogenicity, Omicron variant, spread dynamics, vaccine effectiveness

Downloads

Download data is not yet available.

References

  1. The Japan Times. Should Americans be worried about COVID — again?. [Internet] [cited 2022 March 17].
     Google Scholar
  2. Coronavirus (COVID-19)-Google News.
     Google Scholar
  3. NPR. China battles multiple COVID-19 outbreaks, driven by stealth omicron. [Internet] [2022 March 14].
     Google Scholar
  4. Hindustan Times. Stealth omicron: Know the common symptoms from experts. [Internet] [2022 March 15].
     Google Scholar
  5. The Japan Times. New COVID-19 cases in Japan surge by over 100,000 as serious cases rise to 1,100. [Internet] [cited 2022 February
     Google Scholar
  6. .
     Google Scholar
  7. Hindustan Times. Omicron Is 40% deadlier than seasonal flu, study finds. [Internet] [cited 2022 March 3].
     Google Scholar
  8. Hindustan Times. India sees 3,116 new Covid cases in lowest daily rise since May 2020. [Internet] [2022 March 13].
     Google Scholar
  9. Hindustan Times. Vaccination for 12-15 age group to kick-start today. [Internet] [2022 March 16].
     Google Scholar
  10. The Japan Times. Shionogi seeks approval for Japan’s first domestic COVID pill. [Internet] [2022 February 25].
     Google Scholar
  11. Shervani Z, Khan I, Siddiqui NY, Khan T, Qazi UY. Risk of SARS-CoV-2 Transmission from Humans to Pets and Vice Versa. European
     Google Scholar
  12. Journal of Medical and Health Sciences. 2021; 3(1): 34-38.
     Google Scholar
  13. TIME. Omicron Has Been Found in Deer—That Should Worry Us. [Internet] [cited 2022 February 9].
     Google Scholar
  14. Shervani Z, Bhardwaj D, Sherwani A, Khan I, Qazi UY. COVID-19 infection in 8 big cities of India: The Dynamics of the Spread and Seropositivity. European Journal of Medical and Health Sciences. 2021; 3(6): 1-5.
    DOI  |   Google Scholar
  15. Shervani Z, Bhardwaj D, Nikhat R. COVID-19 infection in India: Seropositivity versus the Dynamics of the Spread. European Journal of Medical and Health Sciences. 2021; 3(4): 95-99.
    DOI  |   Google Scholar
  16. Shervani Z, Bhardwaj D, Nikhat R. Ibbrahim A, Hasan S, Khan I, et al. Serosurvey of Haryana and Odisha: COVID-19 Hybrid Immunity. European Journal of Medical and Health Sciences. 2022; 4(2): 27-32.
    DOI  |   Google Scholar
  17. Shervani Z, Bhardwaj D, Nikhat R. Ibbrahim A, Khan I, Qazi UY, et al. 4th National Sero Survey of India: Vaccine Generated Antibodies Enhancement. European Journal of Medical and Health Sciences. 2022; 4(1): 27-32.
    DOI  |   Google Scholar
  18. Shervani Z, Bhardwaj D, Nikhat R. Ibbrahim A, Khan I, Hasan S, et al. 5th and 6th Sero Survey of Delhi: Vaccine Activated Antibodies Enhancement. European Journal of Medical and Health Sciences. 2022; 4(1): 61-66.
    DOI  |   Google Scholar
  19. Shervani Z. COVID-19 in Kerala: Health Index Theory. European Journal of Medical and Health Sciences. 2021; 3(2): 21-24.
    DOI  |   Google Scholar
  20. Shervani Z. COVID-19 in Kerala: The Dynamics of Spread and Health Index Theory. RAS Medical Science. 2021; 1(2): 1-3.
    DOI  |   Google Scholar
  21. Shervani Z, Bhardwaj D, Nikhat R. Dharavi Slums (Mumbai, India): The Petri Dish of COVID-19 Herd Immunity. European Journal of Medical and Health Sciences. 2021; 3(3): 38-41.
    DOI  |   Google Scholar
  22. Shervani Z, Khan I, Siddiqui NY, Khan T, Qazi UY. Viability of SARS-CoV-2 and Sanitization Methods. European Journal of Medical and Health Sciences. 2021; 3(1): 22-27.
    DOI  |   Google Scholar
  23. Shervani Z, Khan I, Qazi UY. COVID-19 vaccine. Advances in Infectious Diseases. 2020; 10(3): 195-210.
    DOI  |   Google Scholar
  24. Shervani Z, Khan I, Khan T, Qazi UY. World’s fastest supercomputer picks COVID-19 drug. Advances in Infectious Diseases. 2020; 10(3): 211-225.
    DOI  |   Google Scholar
  25. Our World in Data. [Internet] Available from: https://ourworldindata.org
     Google Scholar
  26. Hindustan Times. Not just Delta Plus, 3 other variants of coronavirus pose threat. [Internet] [2021 June 29].
     Google Scholar
  27. BBC News. Delta plus India: Scientists say too early to tell risk of Covid-19 variant. [Internet] [2021 June 23].
     Google Scholar
  28. Shervani Z, Bhardwaj D, Nikhat R. Ibbrahim A, Hasan S, Khan I, et al. The Omicron Variant: Prevalence, Transmission, and Pathogenicity. European Journal of Medical and Health Sciences. 2022; 4(3): 84–91.
    DOI  |   Google Scholar
  29. COVID-19 Bharat. [Internet] Available from: https://covid19bharat.org
     Google Scholar
  30. The Times of India. Genome sequencing shows 4 out of 5 cases reported in Jan caused by Omicron variant. [Internet] [cited 2022 January 28].
     Google Scholar
  31. India Today. Delhi: Genome sequencing reveals Omicron variant in 38% samples from city. [Internet] [cited 2021 December 30].
     Google Scholar
  32. Omicron Found in 65% Delhi Samples Whose Report Came Between January 1-3. [Internet] [cited 2022 January 5] Available from: https://www.ndtv.com
     Google Scholar
  33. Mumbai’s sixth genome sequencing: Omicron found in 2 per cent samples. [Internet] [cited 2021 December 16] Available from: https://www.mid-day.com
     Google Scholar
  34. The Indian Express. Genome sequencing shows Omicron variant predominant strain in Covid cases in Mumbai. [Internet] [cited 2022 March 4].
     Google Scholar
  35. Hindustan Times. Omicron in India infected younger population: Govt data on 3rd wave. [Internet] [cited 2022 February 4].
     Google Scholar
  36. Hindustan Times. Unvaccinated people made up for 92% of Covid deaths in 2022: Govt data. [Internet] [cited 2022 March 4].
     Google Scholar
  37. Reveals ICMR Survey. Omicron-driven 3rd Covid Has More Younger Patients, Deaths due to co-morbidities. [Internet] [cited 2022 February 4].
     Google Scholar
  38. Hindustan Times. No surge in Covid-19 cases, but vulnerable lag in full vaccination. [Internet] [cited 2021 December 20].
     Google Scholar
  39. The Hindu Business Line. More than 70% of 45+ group have got 2 shots. [Internet] [cited 2021 December 7].
     Google Scholar


Most read articles by the same author(s)

1 2 > >>